Psychosis Risk From Cannabis Returned to Baseline After About 9 Months of Abstinence

In a large European case-control study, the elevated psychosis risk associated with cannabis use declined after quitting and returned to never-user levels after approximately 37 weeks of abstinence, though heavy users of high-potency cannabis may retain elevated risk longer.

Bond, Benjamin W et al.·Canadian journal of psychiatry. Revue canadienne de psychiatrie·2025·Strong EvidenceCase-Control
RTHC-06091Case ControlStrong Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Case-Control
Evidence
Strong Evidence
Sample
Not reported

What This Study Found

Ex-users who stopped 1-4 weeks prior had 6.9 times the psychosis odds of never-users. This declined progressively: those who stopped 37-96 weeks prior had no significant elevation (OR 1.01). However, preliminary results suggested frequent users of high-potency cannabis might maintain elevated risk even beyond 181 weeks of abstinence.

Key Numbers

Ex-users stopped 1-4 weeks: OR 6.89; stopped 37-96 weeks: OR 1.01 (not significant); stopped 97-180 weeks: OR 0.73 (not significant); stopped 181+ weeks: OR 1.18 (not significant); frequent high-potency users may retain elevated risk beyond 181 weeks; data from multiple European sites and Brazil

How They Did This

Case-control study from the EU-GEI network collecting data from first-episode psychosis patients and population controls across sites in Europe and Brazil (May 2010 to April 2015). Adjusted logistic regression examined how psychosis odds changed with time since cannabis cessation.

Why This Research Matters

This is the first large multi-site study to quantify how quickly psychosis risk declines after stopping cannabis. The finding that risk returns to baseline after about 9 months offers concrete information for people considering quitting, while the caveat about high-potency use adds important nuance.

The Bigger Picture

The reversibility of cannabis-associated psychosis risk has been a critical unanswered question. This study suggests that for most users, the elevated risk is not permanent, which could motivate cessation efforts. The exception for high-potency users aligns with growing concerns about modern cannabis products.

What This Study Doesn't Tell Us

Case-control design cannot prove causation, relies on retrospective self-report of cannabis use timing, the high-potency finding is preliminary with wide confidence intervals, may not generalize to all populations, does not account for all potential confounders

Questions This Raises

  • ?Is the 37-week threshold consistent across different genetic risk profiles?
  • ?Does the persistent risk for high-potency users reflect permanent brain changes?
  • ?Would similar results appear in non-European populations?

Trust & Context

Key Stat:
Psychosis risk returned to never-user levels after approximately 37 weeks of cannabis abstinence
Evidence Grade:
Large multi-site case-control study across Europe and Brazil with adjusted analyses; strong design but retrospective self-report of cessation timing
Study Age:
Published 2025
Original Title:
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques.
Published In:
Canadian journal of psychiatry. Revue canadienne de psychiatrie, 70(3), 182-193 (2025)
Database ID:
RTHC-06091

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-ControlFollows or compares groups over time
This study
Cross-Sectional / Observational
Case Report / Animal Study

Compares people with a condition to similar people without it.

What do these levels mean? →

Frequently Asked Questions

How long does it take for psychosis risk to normalize after quitting cannabis?

In this study, the elevated psychosis risk associated with cannabis use returned to never-user levels after approximately 37 weeks (about 9 months) of abstinence for most users.

Does the type of cannabis matter for psychosis risk after quitting?

Preliminary results suggested that frequent users of high-potency cannabis may retain an elevated psychosis risk even after more than 3.5 years of abstinence, while users of lower-potency products saw their risk normalize sooner.

Read More on RethinkTHC

Cite This Study

RTHC-06091·https://rethinkthc.com/research/RTHC-06091

APA

Bond, Benjamin W; Duric, Bea; Spinazzola, Edoardo; Trotta, Giulia; Chesney, Edward; Li, Zhikun; Quattrone, Diego; Tripoli, Giada; Gayer-Anderson, Charlotte; Rodriguez, Victoria; Ferraro, Laura; La Cascia, Caterina; Tarricone, Ilaria; Szöke, Andrei; Arango, Celso; Bobes, Julio; Bernardo, Miquel; Del-Ben, Cristina Marta; Menezes, Paulo Rossi; Selten, Jean-Paul; Rutten, Bart P F; de Haan, Lieuwe; Stilo, Simona; Schürhoff, Franck; Pignon, Baptiste; Freeman, Tom P; Vassos, Evangelos; Murray, Robin M; Austin-Zimmerman, Isabelle; Di Forti, Marta. (2025). Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques.. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 70(3), 182-193. https://doi.org/10.1177/07067437241290187

MLA

Bond, Benjamin W, et al. "Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques.." Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2025. https://doi.org/10.1177/07067437241290187

RethinkTHC

RethinkTHC Research Database. "Cannabis Use Cessation and the Risk of Psychotic Disorders: ..." RTHC-06091. Retrieved from https://rethinkthc.com/research/bond-2025-cannabis-use-cessation-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.